ML1808
Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease
PreclinicalActive
Key Facts
Indication
Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease
Phase
Preclinical
Status
Active
Company
About Medilabo
Medilabo develops intranasal drug delivery technology to treat neurodegenerative diseases by directly targeting the brain via the olfactory nerve.
View full company profile